# Hutchmed (HCM) — News

HCM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/hcm/news

## Recent headlines

- [Hutchmed: Global trial of KRAS-EGFR-antibody conjugate therapy](https://www.ainvest.com/news/hutchmed-global-trial-kras-egfr-antibody-conjugate-therapy-2609) — AInvest Wire, Sep 28, 2026
- [Specialty Program Group buys HCM unlocked](https://www.ainvest.com/news/specialty-program-group-buys-hcm-unlocked-2609) — AInvest Wire, Sep 24, 2026
  Specialty Program Group LLC (SPG), a leading operator of specialty insurance brokerage, underwriting, and consulting facilities, has acquired forensic payroll consulting services . This acquisition aligns with SPG’s ongoing strategy to expand its portfolio through targeted mergers and acquisitions,…
- [Hutchmed China Ltd - Hutchmed licenses KRAS-EGFR-antibody to GSK](https://www.ainvest.com/news/hutchmed-china-hutchmed-licenses-kras-egfr-antibody-gsk-2609) — AInvest Wire, Sep 3, 2026
  HUTCHMED (China) Limited (Nasdaq/AIM: HCM; HKEX: 13) has entered into an exclusive development and license agreement with a subsidiary of GSK plc for HMPL-A830, a first-in-class KRAS-EGFR Antibody-Targeted Therapy Conjugate ("ATTC"). The agreement grants the GSK subsidiary worldwide rights,…
- [Hutchmed: Licensing pact with GSK for KRAS-EGFR-antibody conjugate](https://www.ainvest.com/news/hutchmed-licensing-pact-gsk-kras-egfr-antibody-conjugate-2609) — AInvest Wire, Sep 3, 2026
- [Hutchmed trial shows pfs benefit in met+ EGFR-mutated lung ca](https://www.ainvest.com/news/hutchmed-trial-shows-pfs-benefit-met-egfr-mutated-lung-ca-2608) — AInvest Wire, Aug 31, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).